Low levels of inorganic lead noncompetitively inhibit mu-calpain

Toxicology. 1998 Nov 16;131(2-3):169-74. doi: 10.1016/s0300-483x(98)00127-9.

Abstract

Calpain is a ubiquitous calcium-dependent cysteine protease, whose cytoskeletal protein substrates suggest that it may be important in neuronal differentiation. Lead (Pb2+) is known to substitute for Ca2+ in a variety of intracellular processes, and interferes with the development of hippocampal neurons in vitro. We found that free Pb2+ at 1 nM does not activate calpain in the absence of Ca2+. Pb2+ inhibited the activity of calpain; the degree of calpain inhibition was dependent on an interaction between concentrations of both Ca2+ and Pb2+. In the presence of 1 microM free Ca2+, 10 pM free Pb2+ reduced calpain activity, but in the presence of 100 microM free Ca2+, 1 nM free Pb2+ failed to inhibit calpain. This provides evidence that Pb2+ competes for the Ca2+ binding sites on calpain. In the presence of 40 microM free Ca2+, 1 nM free Pb2+ significantly reduces Vmax without altering Km, suggesting that Pb2+ acts as a noncompetitive inhibitor of calpain. Inhibition of calpain is one mechanism by which Pb2+ may interfere with neuronal development.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Calcium / pharmacology
  • Calpain / antagonists & inhibitors*
  • Cysteine Proteinase Inhibitors / toxicity*
  • Kinetics
  • Lead / toxicity*

Substances

  • Cysteine Proteinase Inhibitors
  • Lead
  • Calpain
  • Calcium